Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...

Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide, the active ingredient of Novo Nordisk's blockbuster diabetes and weight-loss drug Ozempic, Hypera's chief ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

The annual meeting of the American Academy of Orthopaedic Surgeons was held from March 10 to 14 in San Diego, drawing ...

A new study links semaglutide, the active ingredient in Ozempic and Wegovy, to a higher risk of hair loss, especially in ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

There's mounting evidence to suggest that GLP-1 medications such as Ozempic and Wegovy may help combat aging and age-related ...

Introduction of a direct-to-patient delivery model for its weight-loss drug in the United States could potentially delay its ...

The social media post has garnered nearly 12.7 million views A man from Toronto, Canada, took running to a whole new level by combining fitness, technology, and art in a unique way. How? He ...

No rushing of Franklin for Tar Heel fans Saturday night, but some are still keeping up hope that they can punch a ticket to the NCAA tournament. "A month ago this team looked so lost and now the ...

Adityanath praised Microsoft chairperson Satya Nadella for bolstering presence in north India and said the tech giant's investment in UP reaffirmed the state's attractiveness for businesses.

I don’t want to overstate the findings; this is still a very preliminary paper which may not stand up to larger samples on more focused outcomes. Semaglutide also has well-known downsides which ...